Definitive Contract 75N92022C00012

Award Date 5/2/22
Potential Completion Date 5/1/24
Potential Value $23M
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Branchburg, NJ 08876, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Roche Diagnostics Corporation for $15,445.60. The contract, which does not have a set-aside designation, is for the delivery of DABMAP KIT medical supplies. Roche Diagnostics, a manufacturer and distributor of in vitro diagnostics, laboratory instruments, and related products and services, has a history of...
This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $22,902.60, was awarded to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for "DRUGS AND BIOLOGICALS" and has a...
This is a Firm Fixed Price delivery order contract awarded by the National Cancer Institute (part of the Department of Health and Human Services) to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $26,365.32 contract is for the provision of unspecified products and services, with a period of performance ending on April 14, 2016. This award is associated with a larger Indefinite Delivery Contract or Blanket Purchase Agreement held...
The federal contract award in the information provided is to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract, valued at $3,118.40, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services. The contract is for the purchase of unspecified medical equipment and supplies, without a set-aside...
This is a $15,649.32 firm fixed price purchase order awarded by the National Cancer Institute, a civilian agency within the Department of Health and Human Services, to Roche Diagnostics Corporation. The service agreement, which has no set-aside designation, covers the supply of laboratory instruments, reagents, test kits, and associated products and services through December 2025. Roche Diagnostics, a manufacturer of in vitro diagnostics, holds several Indefinite Delivery Vehicles and Blanket...
This is a $3,118.40 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Roche Diagnostics Corporation. The contract is not set aside for any specific business type. Roche Diagnostics, a manufacturer of in vitro diagnostics and associated products and services, is providing critical care analyzers, reagents, test kits, and related laboratory equipment, supplies, and services to...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Roche Diagnostics Corporation for the provision of KAPA buffers, probes, and reagents. The contract award, valued at $44,713.33, has an ultimate completion date of September 25, 2024. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a Firm Fixed Price Delivery Order worth $3,954.80 issued by the National Cancer Institute, which is a civilian agency within the Department of Health and Human Services. The award provides Roche Diagnostics, a manufacturer of in vitro diagnostics, reagents, and laboratory equipment, with the authority to supply critical care analyzers, reagents, test kits, and associated laboratory products...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The $3,452.60 contract is for the delivery of unspecified products or services. The award is not designated as a set-aside. Roche Diagnostics is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Roche Diagnostics Corporation for $33,063.35. The contract is for reagents required for staining histological samples in flu research, with a completion date of September 26, 2024. The contract has no set-aside designation. Roche Diagnostics Corporation is a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and...

This is a $22,624,000.00 firm fixed price definitive contract awarded by the National Institute of Biomedical Imaging and Bioengineering, a civilian federal agency, to Roche Molecular Systems Inc. for RADX products and services. The contract has a period of performance through May 1, 2024 and does not have a set-aside designation. The award was made on May 2, 2022 and the contractor, Roche Molecular Systems Inc., is a for-profit manufacturer of goods.

Generated 9/5/24, 10:11 AM